Left ventricular assist devices

Heart

Volumn 96, Issue 1, 2010, Pages 63-71

  Birks, E J ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONVALESCENCE; DETERIORATION; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HUMAN; PRIORITY JOURNAL; REVIEW; SURVIVAL; TECHNOLOGY; TREATMENT INDICATION; ARTICLE; FORECASTING; HEART TRANSPLANTATION; HEART VENTRICLE; PATHOPHYSIOLOGY; PROSTHESIS; STATISTICS;

FORECASTING; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; PROSTHESIS DESIGN; RECOVERY OF FUNCTION;

EID: 75349109129     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2007.130740     Document Type: Review

References (49)

1. De Bakey M. Left ventricular bypass pump for cardiac assistance. Am J Cardiol 1971;27:3.
2. Cooley D, Liotta D, Hallman G. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 1969;24:723.
3. De Bakey M. The odyssey of the artificial heart. Artificial Organs 2000;24:405.
4. Kirklin JK, Frazier OH. Developmental history of mechanical circulatory support. In: Frazier OH, Kirklin JK, eds. Mechanical circulatory support. Amsterdam: Elsevier, 2006. [ISHLT Monograph Series.]
5. Copeland J, Smith R, Icenogle T, et al. Orthotopic total artificial heart bridge to transplantation: preliminary results. J Heart Lung Transplant 1989;8:124-38.
6. Norman JC, Dasco CC, Reul GJ, et al. Partial artificial heart (ALVAD) use with subsequent cardiac and renal allografting in a patient with stone heart syndrome. Artificial Organs 1978;2:413-20.
7. Portner P, Oyer P, McGregor C. First human use of an electrically powered implantable ventricular assist system. Artificial Organs 1985;9:36.
8. Birks EJ, Tansley PD, Yacoub MH, et al. Incidence and clinical management of life-threatening Left ventricular assist device (LVAD) failure. J Heart Lung Transplant 2004;23:964-9.
9. Rogers JG, Butler J, Lansman SL, et al, INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007;50:741-7.
10. Haj-Yahia S, Birks EJ, Rogers P, et al. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg 2007;134:199-203.
11. Deng MC. Cardiac transplantation. Heart 2002;87:177-84.
12. Hankins S, Mancini D. Listing and treatment of status 1 patients. Curr Opin Organ Transplant 2001;6:216-21.
13. Young JB. Heart failure's near dead and dying. J Am Coll Cardiol 2007;50:1291-3.
14. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation. J Am Coll Cardiol 2007;50:1282-90.
15. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the Heartmate vented electric left ventricular assist sytem in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122:1186-95.
16. Navia JL, McCarthy PM, Hoercher KJ, et al. Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg 2002;74:2051-62.
17. El-Banayosy A, Arusoglu L, Kizner L, et al. Predictors of survival in patients bridged to transplantation with the Thoratec VAD device: a single-centre retrospective study on more than 100 patients. J Heart Lung Transplant 2000;19:964-8.
18. Sun BC, Catanese KA, Spanier TB, et al. 100 Long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg 1999;68:688-94.
19. DeRose JJR, Michael A, Sun B, et al. Implantable left ventricular assist devices: an evolving long-term cardiac replacement therapy. Ann Surg 1997;226:461-70.
20. Miller LW, Pagani FD, Russell SD, et al. HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96.
21. Conte JV, Miller LW, Pagani FD, et al. One year follow up with a continuous flow LVAD as a bridge to heart transplantation. J Heart Lung Transplant 2008;27(2S):S244.
22. Esmore D, Kaye D, Spratt P, et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant 2008;27:579-88.
23. Nojiri C, Fey O, Jaschke F, et al. Long-term circulatory support with the Duaheart Msglev centrifugal left ventricular assist system for advanced heart failure patients eligible to transplantation: European Experiences. J Heart Lung Transplant 2008;27(2S):S245.
24. Wieselthaler GM, Streuber M, O'Driscoll GA, et al. Experience with the novel Heartware HVAD with hydromagnetically levitated rotor in a multinstitutional trial. J Heart Lung Transplant 2008;27(2S):S25.
25. Lietz K, Deng M, Morgan J, et al. Mancini. Selection of UNOS status 1A candidates for mechanical circulatory support as bridge-to-transplantation (BTT) - analysis of UNOS/OPTN 2000-2005. J Heart Lung Transplant 2008;27(2S):S244.
26. Frazier OH, Benedict CR, Radovacevic B, et al. Improved left ventricular function after chronic ventricular unloading. Ann Thorac Surg 1996;62:675-82.
27. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-84.
28. Dandel M, Weng Y, Siniawski H, et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005;112(Suppl):I37-45.
29. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383-9.
30. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 2005;112(Suppl):I32-6.
31. Frazier OH, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 1999;68:734-41.
32. Farrar DJ, Holman WR, McBride LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002;21:516-21.
33. Yacoub MH. A novel strategy to maximise the efficacy of LVADs as a bridge to recovery. Eur Heart J 2001;22:534-40.
34. Wong K, Boheler K, Bishop J, et al. Pharmacological modulation pressure overload cardiac hypertrophy changes in ventricular function, extracellular matrix and gene expression. Circulation 1997;96:2239-46
35. Wong K, Boheler KR, Bishop J, et al. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc Res 1998;37:115-22.
36. George RS, Yacoub MH, Bowles CT, et al. Quality of life following LVAD removal for myocardial recovery. J Heart Lung Transplant 2008;27:165-72.
37. Birks EJ, Hall JL, Barton PJ, et al. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation 2005;112(Suppl):I57-64.
38. Hall JL, Birks EJ, Grindle S, et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007;28:613-27.
39. Latif N, Yacoub MH, George R, et al. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung Transplant 2007;26:230-5.
40. Cullen ME, Yuen AH, Felkin LE, et al. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized following recovery: potential implications for local creatine synthesis. Circulation 2006;114:16-20.
41. Rose EA, Gelijins AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
42. Stevenson LW, Miller LW, Desvigne-Nickens P, et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy. A subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure). Circulation 2004;110:975-81.
43. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005;129:9-17.
44. Long JW, Kfoury AG, Slaughter MS, et al. Long term destination therapy with the Heartamte XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 2005;11:133-8.
45. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505.
46. De Robertis F, Rogers P, Amrani M, et al. Bridge to decision using the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant 2008;27:474-8.
47. Letsou GV, Shah N, Gregoric ID, et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005;24:105-9.
48. Miller LW, Nelson KE, Bostic RR, et al. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant 2006;25:778-84.
49. Oz MC, Gelijins AC, Miller L, et al. Left ventricular assist devices as permanent heart failure therapy. The price of progress. Ann Surg 2003;238:577-85.